Association between First-Year Virologic Response to Raltegravir and Long-Term Outcomes in Treatment-Experienced Patients with HIV-1 Infection

類似資料

• Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials
  著者:: Eron, Joseph J, 等
  出版事項: (2013)
• Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials
  著者:: Steigbigel, Roy T., 等
  出版事項: (2010)
• Long-Term Safety from the Raltegravir Clinical Development Program
  著者:: Teppler, Hedy, 等
  出版事項: (2011)
• 2487. Low Rate of Virologic Failure in Antiretroviral Experienced Patients Prescribed Once Daily Raltegravir
  著者:: Hsu, Ricky, 等
  出版事項: (2019)
• Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients
  著者:: Mata-Marín, José Antonio, 等
  出版事項: (2017)